ISDA

Deposition Date 2015-01-08

Release Date 2015-04-29

Last Version Date 2024-11-20

Entry Detail

PDB ID:

5AEP

Keywords:

TRANSFERASE

Title:

Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

SPODOPTERA FRUGIPERDA

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.95 Å

R-Value Free:

0.21

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:TYROSINE-PROTEIN KINASE JAK2
Gene (Uniprot):JAK2
Chain IDs:A
Chain Length:298
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:O60674 Pfam ID:PF07714 EC:2.7.10.2

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
PTR	A	TYR	O-PHOSPHOTYROSINE

Ligand Molecules

QUP

Primary Citation

Novel Pyrrole Carboxamide Inhibitors of Jak2 as Potential Treatment of Myeloproliferative Disorders.

Brasca, M.G, Gnocchi, P, Nesi, M, Amboldi, N, Avanzi, N, Bertrand, J, Bindi, S, Canevari, G, Casero, D, Ciomei, M, Colombo, N, Cribioli, S, Fachin, G, Felder, E.R, Galvani, A, Isacchi, A, Motto, I, Panzeri, A, Donati, D.Show

Bioorg.Med.Chem. 23 2387 ? (2015)

PMID: 25882525 DOI: 10.1016/J.BMC.2015.03.059

Abstact

Compound 1, a hit from the screening of our chemical collection displaying activity against JAK2, was deconstructed for SAR analysis into three regions, which were explored. A series of compounds was synthesized leading to the identification of the potent and orally bioavailable JAK2 inhibitor 16 (NMS-P830), which showed an encouraging tumour growth inhibition in SET-2 xenograft tumour model, with evidence for JAK2 pathway suppression demonstrated by in vivo pharmacodynamic effects.

Legend

Protein

Chemical

Disease

Primary Citation of related structures